0001209191-19-046445.txt : 20190819
0001209191-19-046445.hdr.sgml : 20190819
20190819061824
ACCESSION NUMBER: 0001209191-19-046445
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190815
FILED AS OF DATE: 20190819
DATE AS OF CHANGE: 20190819
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Becker Marc A.
CENTRAL INDEX KEY: 0001618060
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36310
FILM NUMBER: 191034808
MAIL ADDRESS:
STREET 1: 175 CROSSING BLVD.
STREET 2: 4TH FLOOR
CITY: FRAMINGHAM
STATE: MA
ZIP: 01702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001367920
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: SUITE 3000N
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-860-0045
MAIL ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: SUITE 3000N
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060628
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-15
0
0001367920
CONCERT PHARMACEUTICALS, INC.
CNCE
0001618060
Becker Marc A.
C/O CONCERT PHARMACEUTICALS, INC.
65 HAYDEN AVENUE, SUITE 3000N
LEXINGTON
MA
02421
0
1
0
0
CFO, PFO
Common Stock
2019-08-15
4
A
0
28093
A
28093
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of the Issuer.
35% of the RSUs granted to Mr. Becker will vest on August 15, 2020, and the remaining 65% of the RSUs will vest on August 15, 2021. The number above represents the maximum number of shares that may be delivered pursuant to the award.
Not applicable.
/s/ Ryan Lynch as attorney-in-fact for Marc Becker
2019-08-19